A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa

NCT03231449 | Unknown

• 1 other identifier: 001
• Study Type: observational
• Target: 5,000
• Locations: 12 countries
• Sites: 19

Brief Summary

FEVRIER study is an observatory of hospitalizations in cardiology units in sub-Saharan Africa.

Conditions

Acute Coronary Syndrome; Heart Failure; Syncope; Stroke; Pericarditis; Endocarditis; Conduction Abnormalities; Rhythm; Abnormal; Pulmonary Embolism; Deep Vein Thrombosis; Other Cardiovascular Conditions

Keywords

routine care, evaluation, Africa, observatory

Outcome Measures

Primary Outcomes (6)

• Description of patients in cardiology unit in sub-Saharan Africa:socio-demographic characterization

  low/medium low / medium high/high

  5 years

• Description of patients in cardiology unit in sub-Saharan Africa:causes of hospitalization

  one answer with main reason for hospitalization

  5 years

• Description of patients in cardiology unit in sub-Saharan Africa: co-morbidities

  cardiovascular risk factors/history of cardiovascular disease/kidney disease/cancer/alcoholism/psychiatric disorder/sickle cell anemia/HIV:Hepatitis/tuberculosis/other

  5 years

• Description of patients in cardiology unit in sub-Saharan Africa: hospital examinations

  blood test/ECG/Chest Xray/Echocardiography/Coronarography/Brain scan

  5 years

• Description of patients in cardiology unit in sub-Saharan Africa: duration of hospitalization

  number of days spent in cardiology departement

  5 years

• Description of patients in cardiology unit in sub-Saharan Africa: discharge diagnosis

  medical conclusion

  5 years

Secondary Outcomes (3)

• number of patients with heart failure

  5 years

• number of patients with myocardial infarction

  5 years

• number of patients with atrial fibrillation

  5 years

Interventions

observation of current care OTHER

The study FEVRIER (survey of hospitalizations in cardiology units in sub-Saharan Africa) aims to establish a description of sub-Saharan standard of care, in order to get a cross sectional analysis (globally and per country) and a longitudinal analysis (evolution during 5 years).

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Each patient hospitalized in cardiology unit of participating centers during the month of February can be included.

You may qualify if:

• to be hospitalized in a cardiology department of a participating center during the month of February

You may not qualify if:

• refusal

Sponsors & Collaborators

• Cardiologie et Développement: lead
• Institut National de la Santé Et de la Recherche Médicale, France: collaborator

Study Sites (20)

Centre national hospitalier et universitaire Koutoukou Maga

Cotonou, Benin

Location

Centre médical Paul IV

Ouagadougou, Burkina Faso

Location

Hopital militaire de Kamenge et polyclinique maison médicale

Bujumbura, Burundi

Location

Hôpital Régional

Bafoussam, Cameroon

Location

Douala General Hospital

Douala, Cameroon

Location

Central Hospital

Yaoundé, Cameroon

Location

Hôpital Général de Yaoundé

Yaoundé, Cameroon

Location

Institut de Cariologie d'Abidjan

Abidjan, Côte d’Ivoire

Location

CHU

Bouaké, Côte d’Ivoire

Location

Clinique Ngaliema

Kinshasa, Democratic Republic of the Congo

Location

Clinique universitaire de Kinshasa

Kinshasa, Democratic Republic of the Congo

Location

Centre Hospitalier Universitaire (CHUL)

Libreville, Gabon

Location

CHU Ignace Deen

Conakry, Guinea

Location

Institut du coeur

Maputo, Mozambique

Location

Hôpital National Lamorde

Niamey, Niger

Location

CHU

Brazzaville, Republic of the Congo

Location

Hôpital de Fann

Dakar, Senegal

Location

Hôpital général de Grand Yoff

Dakar, Senegal

Location

El Hadj-Ibrahima Niass

Kaolack, Senegal

Location

National Cardiothoracic center / Shab Teaching Hospital

Khartoum, Sudan

Location

Related Publications (6)

• Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007 Aug 2;357(5):470-6. doi: 10.1056/NEJMoa065085.

  PMID: 17671255 BACKGROUND

• Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B, Mocumbi AO, Paquet C, Sidi D, Jouven X. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009 Aug 25;120(8):663-8. doi: 10.1161/CIRCULATIONAHA.109.849190. Epub 2009 Aug 10.

  PMID: 19667239 BACKGROUND

• Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012 Mar 10;379(9819):953-964. doi: 10.1016/S0140-6736(11)61171-9.

  PMID: 22405798 BACKGROUND

• Ranque B, Menet A, Diop IB, Thiam MM, Diallo D, Diop S, Diagne I, Sanogo I, Kingue S, Chelo D, Wamba G, Diarra M, Anzouan JB, N'Guetta R, Diakite CO, Traore Y, Legueun G, Deme-Ly I, Belinga S, Boidy K, Kamara I, Tharaux PL, Jouven X. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study. Lancet Haematol. 2014 Nov;1(2):e64-73. doi: 10.1016/S2352-3026(14)00007-6. Epub 2014 Oct 28.

  PMID: 27030156 BACKGROUND

• Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Sidi D, Jouven X. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ. 2008 Feb;86(2):84. doi: 10.2471/blt.07.046680. No abstract available.

  PMID: 18297157 BACKGROUND

• Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014 Aug 28;371(9):818-27. doi: 10.1056/NEJMoa1311890.

  PMID: 25162888 BACKGROUND

MeSH Terms

Conditions

Acute Coronary Syndrome; Heart Failure; Syncope; Stroke; Pericarditis; Endocarditis; Arrhythmias, Cardiac; Pulmonary Embolism; Venous Thrombosis

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Unconsciousness; Consciousness Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Pathologic Processes; Lung Diseases; Respiratory Tract Diseases; Embolism; Embolism and Thrombosis; Thrombosis

Study Officials

• Xavier Jouven, MD, PhD

  cardiologie et Developpement

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: July 21, 2017
• First Posted: July 27, 2017
• Study Start: February 1, 2017
• Primary Completion: December 1, 2020
• Study Completion: February 1, 2021
• Last Updated: May 25, 2018

Record last verified: 2018-05

Data Sharing

• IPD Sharing: Will not share

Locations

GU (1); NI (1); BE (1); BU (1); RE (1); CÔ (2); DE (2); MO (1); CA (4); GA (1); SE (3); SU (1)